ACB appoints biopharmaceutical executive to lead medical cannabis commercial acceleration
Aurora Cannabis (ACB) appoints a seasoned biopharmaceutical executive to lead commercial acceleration of its global medical cannabis business.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.